Engineered stem cell implants can help resynchronize cardiac motion

Washington: Researchers have discovered a method to resynchronize cardiac motion following a heart attack with the help of stem cells.

Scientists implanted engineered stem cells, also known as induced pluripotent stem (iPS) cells, into damaged regions of mouse hearts following a heart attack. This regenerative approach successfully targeted the origin of abnormal cardiac motion, preventing heart failure.

Andre Terzic, M.D., Ph.D., senior author of the study, said that the discovery introduces - for the first time - stem cell-based `biological resynchronization` as a novel means to treat cardiac dyssynchrony.

Muscle damage following a heart attack may disrupt normal heart conduction, resulting in a condition known as cardiac dyssynchrony .

Stem cell-based repair is going to offer a new solution to patients who would otherwise be resistant to device-based resynchronization.

Satsuki Yamada, M.D., Ph.D., first author of the study, said that a high-resolution ultrasound revealed harmonized pumping where iPS cells were introduced to the previously damaged heart tissue.

The study provides evidence that a stem cell-based intervention may be effective in synchronizing failing hearts. Additional studies will follow to validate the value of stem cell-based regenerative solutions in addressing abnormal cardiac motion in heart failure, ultimately leading to improved patient care.

The findings have been published in the Journal of Physiology.


By continuing to use the site, you agree to the use of cookies. You can find out more by clicking this link